Antimicrobial Agents Practice Questions

Q: Which of the following drug classes develops resistance by inactivating enzymes?

All of the above. The primary mechanism of bacterial resistance involves the production of **inactivating enzymes** that chemically modify or destroy the antibiotic before it can reach its target site. 1. **Aminoglycosides:** Resistance most commonly occurs via **group transferases** (enzymes like acetyltransferases, adenyltransferases, and phosphoryltransferases). These enzymes modify the hydroxyl or amino groups of the drug, preventing it from binding to the 30S ribosomal subunit. 2. **Beta-lactams:** The most prevalent mechanism is the production of **Beta-lactamases** (e.g., penicillinase, cephalosporinase, carbapenemase) [1]. These enzymes hydrolyze the cyclic amide bond of the beta-lactam ring, rendering the antibiotic inactive [1, 2]. 3. **Chloramphenicol:** Bacteria produce **Chloramphenicol acetyltransferase (CAT)**. This enzyme acetylates the drug, preventing it from binding to the 50S ribosomal subunit. Since all three classes utilize enzymatic inactivation as a major resistance mechanism, **Option D** is correct. --- ### High-Yield NEET-PG Pearls * **Aminoglycosides:** While enzymatic inactivation is the *most common* mechanism, decreased uptake (porin mutation) is also seen in *Pseudomonas*. * **Beta-lactams:** In *S. aureus* (MRSA), resistance is due to **altered target sites** (PBP2a), not just beta-lactamases. * **Vancomycin:** Resistance occurs via **target site modification** (D-Ala-D-Ala changes to D-Ala-D-Lac). * **Fluoroquinolones:** Resistance primarily occurs through **mutations in DNA gyrase/Topoisomerase IV** and active efflux pumps. * **Tetracyclines:** The most common mechanism is **active efflux** of the drug out of the bacterial cell.

Q: What is the mechanism of action of fluoroquinolones in gram-positive organisms?

Topoisomerase IV. **Explanation:** Fluoroquinolones are bactericidal antibiotics that inhibit bacterial DNA synthesis by targeting two essential enzymes: **DNA gyrase (Topoisomerase II)** and **Topoisomerase IV**. The primary target of fluoroquinolones depends on the type of organism: * **Gram-positive organisms:** The primary target is **Topoisomerase IV**. This enzyme is responsible for the decatenation (separation) of interlinked daughter chromosomes following DNA replication. Inhibition leads to the inability of the bacteria to divide. * **Gram-negative organisms:** The primary target is **DNA gyrase (Topoisomerase II)**, which is responsible for introducing negative supercoils into DNA to relieve torsional strain during replication. **Analysis of Options:** * **Option A & B (DNA gyrase / Topoisomerase II):** These are synonymous in bacteria. While fluoroquinolones do inhibit this enzyme, it is the *primary* target in **Gram-negative** bacteria (e.g., *E. coli*), not Gram-positive ones. * **Option C (Topoisomerase III):** This enzyme is involved in DNA recombination and is not a primary target for fluoroquinolones. * **Option D (Topoisomerase IV):** Correct. In **Gram-positive** bacteria (e.g., *S. pneumoniae*, *S. aureus*), this is the initial and most sensitive target. **High-Yield Clinical Pearls for NEET-PG:** 1. **Resistance Mechanism:** Most commonly occurs via mutations in the **QRDR (Quinolone Resistance-Determining Region)** of the target enzymes or via efflux pumps. 2. **Respiratory Quinolones:** Levofloxacin, Moxifloxacin, and Gemifloxacin are called "respiratory quinolones" due to their enhanced activity against Gram-positive organisms like *S. pneumoniae*. 3. **Contraindications:** Avoid in pregnancy and children (due to potential **cartilage damage/arthropathy**) and in patients with a history of **tendon rupture** or QT prolongation.

Q: All of the following are aminoglycosides except:

Azithromycin. **Explanation:** The correct answer is **Azithromycin** because it belongs to the **Macrolide** class of antibiotics, not Aminoglycosides. **1. Why Azithromycin is the correct answer:** Azithromycin is a broad-spectrum macrolide (along with Erythromycin and Clarithromycin) characterized by a large macrocyclic lactone ring. It acts by binding to the **50S ribosomal subunit**, inhibiting bacterial protein synthesis. It is commonly used for respiratory tract infections, atypical pneumonias, and sexually transmitted infections (Chlamydia). **2. Why the other options are incorrect:** Options A, B, and C are all classic examples of **Aminoglycosides**. Aminoglycosides are characterized by amino sugars linked via glycosidic bonds to a hexose nucleus. They act by binding to the **30S ribosomal subunit**, causing mRNA misreading and inhibition of translocation. * **Streptomycin:** The first aminoglycoside discovered; primarily used today for Tuberculosis (second-line) and Plague. * **Kanamycin:** An older aminoglycoside with significant systemic toxicity, now limited in use. * **Netilmycin:** A semi-synthetic derivative of sisomicin, often resistant to many aminoglycoside-inactivating enzymes. **Clinical Pearls for NEET-PG:** * **Mnemonic for Aminoglycosides:** "STREPT" (Streptomycin, Tobramycin, Gentamicin, Amikacin, Neomycin, Kanamycin, Netilmycin). Note that most end in **"-mycin"** or **"-micin"**. * **Exception Alert:** Do not confuse Macrolides (Erythro**mycin**, Azithro**mycin**) with Aminoglycosides. * **Toxicity:** Aminoglycosides are notorious for **Ototoxicity** (vestibular/cochlear) and **Nephrotoxicity** (Acute Tubular Necrosis). * **Spectrum:** They are bactericidal and primarily effective against **Aerobic Gram-negative bacilli**. They are ineffective against anaerobes because their uptake into the bacteria requires oxygen.

Q: Which drug is an alternative to metronidazole for treating amoebic liver abscess?

Chloroquine. **Chloroquine** is the correct answer because it is a highly effective tissue amoebicide. While Metronidazole (or Tinidazole) remains the drug of choice for amoebic liver abscess (ALA) [1], Chloroquine serves as a potent alternative or adjunct. The pharmacological basis lies in its pharmacokinetics: Chloroquine achieves **very high concentrations in the liver** (several hundred times higher than in plasma), making it lethal to *Entamoeba histolytica* trophozoites residing in hepatic tissue. However, it is ineffective against intestinal amoebiasis as it is rapidly absorbed from the upper GI tract.Analysis of Incorrect Options:* **Ciprofloxacin (A):** This is a fluoroquinolone antibiotic. While it has a broad spectrum against bacteria, it has no significant clinical activity against *E. histolytica*.* **Mebendazole (C):** This is a benzimidazole anthelmintic used primarily for luminal nematodes (like roundworms or whipworms). It acts by inhibiting microtubule synthesis in worms, not protozoa.* **Bephenium Naphthoate (D):** This is an older anthelmintic previously used for hookworm infections. It is not used in the management of amoebiasis.High-Yield Clinical Pearls for NEET-PG:* **Classification:** Amoebicides are divided into **Luminal** (e.g., Diloxanide furoate, Paromomycin, Iodoquinol) and **Tissue** (e.g., Metronidazole, Tinidazole, Chloroquine, Emetine) [1].* **Sequential Therapy:** Treatment of ALA always requires a luminal amoebicide following the tissue amoebicide to eradicate the intestinal reservoir and prevent relapse [1].* **Triple Therapy:** In refractory cases of ALA, a combination of Metronidazole, Chloroquine, and Diloxanide furoate may be used.

Q: Which of the following is NOT true about vancomycin?

Has 95% oral bioavailability. **Explanation:** **1. Why Option A is correct (The Concept):** Vancomycin is a large, complex glycopeptide molecule. Due to its high molecular weight and polar nature, it has **very poor oral bioavailability (<5%)**. It is not absorbed from the gastrointestinal tract into the systemic circulation. Therefore, the statement that it has 95% oral bioavailability is false. **2. Analysis of Incorrect Options:** * **Option B (Inhibits cell wall synthesis):** This is true. Vancomycin inhibits bacterial cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan pentapeptide, preventing cross-linking (transpeptidation). * **Option C (Parenteral and Oral use):** This is true. It is given **IV** for systemic infections (like endocarditis or pneumonia). It is given **orally** specifically for **Clostridioides difficile-associated diarrhea (CDAD)** because it remains in the gut lumen to act locally. * **Option D (Indicated for MRSA):** This is true. Vancomycin is the traditional "gold standard" treatment for Methicillin-resistant *Staphylococcus aureus* (MRSA) infections. **3. High-Yield Clinical Pearls for NEET-PG:** * **Red Man Syndrome:** An infusion-related reaction caused by histamine release; prevented by slowing the infusion rate. * **Spectrum:** Narrow spectrum; active **only** against Gram-positive bacteria. * **Resistance:** Mediated by the replacement of D-Ala-D-Ala with **D-Ala-D-Lac** (seen in VRSA/VRE). * **Adverse Effects:** Ototoxicity and Nephrotoxicity (especially when combined with aminoglycosides). * **Excretion:** Primarily via glomerular filtration; requires dose adjustment in renal failure.

Q: Which of the following groups of antibiotics is used in malaria?

Tetracyclines. **Explanation:** **Why Tetracyclines are the Correct Answer:** Tetracyclines (specifically **Doxycycline** and **Tetracycline**) and the related lincosamide **Clindamycin** possess potent antimalarial activity. They act by targeting the **apicoplast**, a non-photosynthetic plastid organelle in *Plasmodium* species that is essential for parasite survival. By inhibiting protein synthesis within this organelle, these drugs cause a "delayed death" effect, where the parasite survives the first division but fails to survive the second. Due to this slow onset of action, they are never used as monotherapy for acute malaria; instead, they are combined with fast-acting schizonticides like Quinine or Artesunate. **Why Other Options are Incorrect:** * **A. Aminoglycosides:** These inhibit the 30S bacterial ribosome and are primarily used for aerobic Gram-negative infections. They have no clinical role in treating malaria. * **C. Carbapenems:** These are broad-spectrum beta-lactams used for multi-drug resistant bacterial infections (e.g., ESBL producers). They target bacterial cell wall synthesis, which is absent in *Plasmodium*. * **D. Penicillins:** Like carbapenems, these target the peptidoglycan cell wall and are ineffective against protozoal parasites. **High-Yield Clinical Pearls for NEET-PG:** * **Doxycycline** is a first-line agent for **chemoprophylaxis** of malaria in areas with multi-drug resistant *P. falciparum*. * **Clindamycin** is the preferred alternative to Doxycycline for treating malaria in **pregnant women and children** (to avoid tetracycline-induced bone/teeth toxicity). * **Radical cure:** Refers to the eradication of hypnozoites (latent liver stages) of *P. vivax* and *P. ovale*, achieved only by **Primaquine** or **Tafenoquine**.

Q: Which drug is contraindicated in pregnancy?

Tetracycline. **Explanation:** **Tetracycline** is the correct answer because it is a known teratogen. It crosses the placenta and chelates calcium, leading to deposition in fetal bones and teeth. This results in **permanent yellowish-brown discoloration of teeth** and **enamel hypoplasia** if used after the 14th week of gestation. Additionally, it can cause **fetal growth retardation** and carries a high risk of **acute fatty liver necrosis** in the pregnant mother. **Analysis of Incorrect Options:** * **Erythromycin (Option B):** Generally considered safe in pregnancy (Category B). However, the *estolate* salt is avoided due to the risk of cholestatic hepatitis in the mother. * **Ampicillin (Option C):** Penicillins are the drugs of choice in pregnancy for various infections as they lack teratogenic potential. * **Chloroquine (Option D):** It is considered safe and is the drug of choice for treating malaria in pregnant women (except for resistant strains). **NEET-PG High-Yield Pearls:** * **SAFE Drugs in Pregnancy (Mnemonic: "PC-ME"):** **P**enicillins, **C**ephalosporins, **M**acrolides (except Clarithromycin), **E**rythromycin. * **CONTRAINDICATED Drugs (Mnemonic: "SAFE-T"):** **S**ulfonamides (Kernicterus), **A**minoglycosides (Ototoxicity), **F**luoroquinolones (Cartilage damage), **E**rythromycin estolate, **T**etracyclines (Teeth/Bone). * **Thalidomide:** Causes Phocomelia (seal-like limbs). * **Warfarin:** Causes Fetal Warfarin Syndrome (nasal hypoplasia, stippled epiphyses).

Q: Which drugs can be used for outpatient treatment of community-acquired pneumonia?

Azithromycin. **Explanation:** **Correct Answer: D. Azithromycin** Community-acquired pneumonia (CAP) in the outpatient setting is most commonly caused by *Streptococcus pneumoniae*, *Haemophilus influenzae*, and atypical pathogens like *Mycoplasma pneumoniae* or *Chlamydophila pneumoniae*. **Azithromycin**, a macrolide, is a preferred first-line agent for healthy outpatients because it provides excellent coverage against both typical and atypical pathogens. It is orally bioavailable, has a long half-life (allowing for once-daily dosing), and achieves high intracellular concentrations in lung tissue. **Analysis of Incorrect Options:** * **A. Ceftriaxone:** While effective against *S. pneumoniae*, it is a parenteral (IV/IM) third-generation cephalosporin. It is typically reserved for inpatient management or as part of a combination regimen for more severe cases. * **B. Cefazolin:** A first-generation cephalosporin with excellent Gram-positive coverage (especially *S. aureus*) but poor activity against the common respiratory pathogens and no activity against atypical organisms. * **C. Imipenem:** A carbapenem used for serious, multi-drug resistant, or hospital-acquired infections. It must be administered parenterally and is "overkill" for uncomplicated outpatient CAP. **High-Yield Clinical Pearls for NEET-PG:** * **ATS/IDSA Guidelines:** For healthy outpatients with no comorbidities, the preferred drugs are **Amoxicillin (high dose)**, **Doxycycline**, or a **Macrolide** (if local pneumococcal resistance is <25%). * **Atypical Coverage:** Macrolides (Azithromycin) and Tetracyclines (Doxycycline) are the drugs of choice for "Walking Pneumonia" (Mycoplasma). * **Side Effect:** Watch for **QT interval prolongation** with macrolides and fluoroquinolones. * **Ceftriaxone + Azithromycin:** This is the classic "dual therapy" for hospitalized patients to cover both typical and atypical pathogens.

Q: Which antitubercular therapy (ATT) is most commonly implicated in causing peripheral neuropathy?

Isoniazid. ### Explanation **Correct Option: C. Isoniazid (INH)** **Mechanism of Neuropathy:** Isoniazid is the most common antitubercular drug to cause peripheral neuropathy. The underlying mechanism is a **functional deficiency of Pyridoxine (Vitamin B6)**. Isoniazid is chemically similar to pyridoxine; it inhibits the enzyme *pyridoxine phosphokinase*, which converts pyridoxine to its active form, pyridoxal phosphate. Furthermore, isoniazid reacts with pyridoxal phosphate to form a hydrazone complex that is rapidly excreted in the urine. This depletion leads to axonal degeneration of nerves, manifesting as "glove and stocking" paresthesia. **Why other options are incorrect:** * **A. Rifampicin:** Primarily known for its hepatotoxicity and for causing a harmless orange-red discoloration of body fluids (urine, sweat, tears). It is a potent microsomal enzyme inducer. * **B. Pyrazinamide:** Most commonly associated with hyperuricemia (which may precipitate gout) and hepatotoxicity. It does not typically affect peripheral nerves. * **D. Ethambutol:** Its hallmark side effect is **optic neuritis**, resulting in decreased visual acuity and red-green color blindness. It is generally not associated with peripheral neuropathy. **Clinical Pearls for NEET-PG:** * **Prophylaxis:** Peripheral neuropathy can be prevented by co-administering **Pyridoxine (10–25 mg/day)**. * **Risk Factors:** Slow acetylators, malnourished individuals, diabetics, alcoholics, and pregnant women are at a higher risk of INH-induced neuropathy. * **Treatment:** If neuropathy develops, the dose of Pyridoxine is increased to **100 mg/day**. * **Other INH Side Effects:** Hepatotoxicity (most common), Drug-induced Lupus (Anti-Histone antibodies), and Sideroblastic anemia.

Q: Which of the following tetracyclines has the potential to cause vestibular toxicity?

Minocycline. ### Explanation **Correct Option: A. Minocycline** Minocycline is the most lipid-soluble tetracycline. This high lipid solubility allows it to cross the blood-brain barrier and reach high concentrations in the endolymph of the inner ear and the vestibular apparatus. This accumulation leads to **vestibular toxicity**, manifesting as dizziness, ataxia, vertigo, nausea, and vomiting. These symptoms are more common in women and are usually reversible upon discontinuation of the drug. **Analysis of Incorrect Options:** * **B. Demeclocycline:** While it does not cause vestibular toxicity, it is notorious for causing **nephrogenic diabetes insipidus** (by inhibiting ADH action in the collecting duct) and severe **phototoxicity**. * **C. Doxycycline:** This is the most commonly used tetracycline due to its once-daily dosing and safety in renal failure (excreted via bile). It lacks the specific lipid profile required to cause significant vestibular side effects. * **D. Tetracycline:** This is a short-acting, older generation agent. It is primarily associated with gastrointestinal upset and teeth discoloration but does not penetrate the vestibular system significantly. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Doxycycline is the DOC for Rickettsial infections, Chlamydia, Cholera, and Brucellosis (with Rifampicin). * **Fanconi Syndrome:** Expired tetracyclines cause proximal renal tubular acidosis (Fanconi Syndrome). * **SIADH:** Demeclocycline is used therapeutically to treat SIADH because of its side effect profile. * **Contraindications:** Tetracyclines are contraindicated in pregnancy (teratogenic: causes bone growth retardation and tooth enamel hypoplasia) and in children under 8 years of age.

Question 1

Which of the following drug classes develops resistance by inactivating enzymes?

Accepted Answer

All of the above

Answer

Aminoglycosides

Answer

Beta lactams

Answer

Chloramphenicol

Question 2

What is the mechanism of action of fluoroquinolones in gram-positive organisms?

Accepted Answer

Topoisomerase IV

Answer

DNA gyrase

Answer

Topoisomerase II

Answer

Topoisomerase III

Question 3

All of the following are aminoglycosides except:

Accepted Answer

Azithromycin

Answer

Netilmycin

Answer

Streptomycin

Answer

Kanamycin

Question 4

Which drug is an alternative to metronidazole for treating amoebic liver abscess?

Accepted Answer

Chloroquine

Answer

Ciprofloxacin

Answer

Mebendazole

Answer

Bephenium Naphthoate

Question 5

Which of the following is NOT true about vancomycin?

Accepted Answer

Has 95% oral bioavailability

Answer

Inhibits cell wall synthesis

Answer

Can be used parenterally as well as orally

Answer

Is indicated for MRSA infections

Question 6

Which of the following groups of antibiotics is used in malaria?

Accepted Answer

Tetracyclines

Answer

Aminoglycosides

Answer

Carbapenems

Answer

Penicillins

Question 7

Which drug is contraindicated in pregnancy?

Accepted Answer

Tetracycline

Answer

Erythromycin

Answer

Ampicillin

Answer

Chloroquine

Question 8

Which drugs can be used for outpatient treatment of community-acquired pneumonia?

Accepted Answer

Azithromycin

Answer

Ceftriaxone

Answer

Cefazolin

Answer

Imipenem

Question 9

Which antitubercular therapy (ATT) is most commonly implicated in causing peripheral neuropathy?

Accepted Answer

Isoniazid

Answer

Rifampicin

Answer

Pyrazinamide

Answer

Ethambutol

Question 10

Which of the following tetracyclines has the potential to cause vestibular toxicity?

Accepted Answer

Minocycline

Answer

Demeclocycline

Answer

Doxycycline

Answer

Tetracycline

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?